Clinical Trial

Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
To observe the long-term efficacy and safety of autologous non cultured epidermal cell suspension transplantation in the treatment of vitiligo, analyze the correlation between cell density, type, and postoperative efficacy and prognosis, and providing a basis for clinical application.
Trial Details
NCT Number NCT07187882
Lead Sponsor Peking University People's Hospital
Conditions Vitiligo
Enrollment 30 participants
Start Date 2024-04-25
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-23